Sedlaczek P - Search Results

1

p53 autoantibodies in the sera, cyst and ascitic fluids of patients with ovarian cancer.

Montenarh M, Harloziñska A, Bar JK, Kartarius S, Günther J, Sedlaczek P. Montenarh M, et al. Among authors: sedlaczek p. Int J Oncol. 1998 Sep;13(3):605-10. doi: 10.3892/ijo.13.3.605. Int J Oncol. 1998. PMID: 9683801

2

Carcinoembryonic antigen isotypes in tissue sections and loose cyst fluid cells of ovarian neoplasms.

Harłozińska A, Bar JK, Jothy S, Sedlaczek P, Slesak B, Richter R. Harłozińska A, et al. Among authors: sedlaczek p. Tumour Biol. 1993;14(1):1-8. doi: 10.1159/000217819. Tumour Biol. 1993. PMID: 7684152

3

Expression of p53 protein and Ki-67 reactivity in ovarian neoplasms. Correlation with histopathology.

Harlozińska A, Bar JK, Sedlaczek P, Gerber J. Harlozińska A, et al. Among authors: sedlaczek p. Am J Clin Pathol. 1996 Mar;105(3):334-40. doi: 10.1093/ajcp/105.3.334. Am J Clin Pathol. 1996. PMID: 8602615

4

Relation between infection with human papilloma viruses and expression of p21 and p53 oncoproteins in patients with cancer of the uterine cervix.

Bar JK, Markowska J, Harlozińska A, Sedlaczek P, Nowak M, Roszak A. Bar JK, et al. Among authors: sedlaczek p. Eur J Gynaecol Oncol. 1996;17(4):283-5. Eur J Gynaecol Oncol. 1996. PMID: 8856306

5

Prospective studies of p53 and c-erbB-2 expression in relation to clinicopathological parameters of human ductal breast cancer in the second stage of clinical advancement.

Bebenek M, Bar JK, Harlozinska A, Sedlaczek P. Bebenek M, et al. Among authors: sedlaczek p. Anticancer Res. 1998 Jan-Feb;18(1B):619-23. Anticancer Res. 1998. PMID: 9568187

6

Circulating biomarker tissue kallikrein-related peptidase KLK5 impacts ovarian cancer patients' survival.

Dorn J, Magdolen V, Gkazepis A, Gerte T, Harlozinska A, Sedlaczek P, Diamandis EP, Schuster T, Harbeck N, Kiechle M, Schmitt M. Dorn J, et al. Among authors: sedlaczek p. Ann Oncol. 2011 Aug;22(8):1783-90. doi: 10.1093/annonc/mdq701. Epub 2011 Jan 27. Ann Oncol. 2011. PMID: 21273346 Free article.

7

TPS and CA 125 levels in serum, cyst fluid and ascites of patients with epithelial ovarian neoplasms.

Harłozinska A, Sedlaczek P, Van Dalen A, Rozdolski K, Einarsson R. Harłozinska A, et al. Among authors: sedlaczek p. Anticancer Res. 1997 Nov-Dec;17(6D):4473-8. Anticancer Res. 1997. PMID: 9494553

8

Relations between the expression of p53, c-erbB-2, Ki-67 and HPV infection in cervical carcinomas and cervical dysplasias.

Bar JK, Harłozińska A, Sedlaczek P, Kasiak J, Markowska J. Bar JK, et al. Among authors: sedlaczek p. Anticancer Res. 2001 Mar-Apr;21(2A):1001-6. Anticancer Res. 2001. PMID: 11396132

9

Vascular endothelial growth factor (VEGF) concentration in sera and tumor effusions from patients with ovarian carcinoma.

Harlozinska A, Sedlaczek P, Kulpa J, Grybos M, Wójcik E, Van Dalen A, Einarsson R. Harlozinska A, et al. Among authors: sedlaczek p. Anticancer Res. 2004 Mar-Apr;24(2C):1149-57. Anticancer Res. 2004. PMID: 15154640 Free article.

10

Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.

Sedlaczek P, Frydecka I, Gabryś M, Van Dalen A, Einarsson R, Harłozińska A. Sedlaczek P, et al. Cancer. 2002 Nov 1;95(9):1886-93. doi: 10.1002/cncr.10917. Cancer. 2002. PMID: 12404282 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters